Idiopathic hypersomnia without long sleep time is a sleep disorder characterized almost entirely by constant excessive daytime drowsiness lasting more than 3 months, with involuntary more or less rest...
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding idiopathic hypersomnia without long sleep time is largely due to its rarity and the lack of systematic clinical studies. As this condition affects a small population, comprehensive research has been challenging. Additionally, the absence of identified genetic factors and clear clinical features complicates the understanding and characterization of this disorder. However, ongoing research efforts may provide more insights in the future.
To navigate your condition effectively, consider consulting a sleep specialist with expertise in hypersomnia disorders. They can provide tailored management strategies and support. Additionally, engaging with resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and guidance. While there are currently no known patient organizations for this specific condition, participating in clinical trials may also offer access to new treatments and contribute to research efforts.
There are several orphan drugs designated for this condition, including mazindol, pentetrazol, pitolisant, serdexmethylphenidate, and sodium oxybate, although only sodium oxybate has received FDA approval. Currently, there is one active clinical trial related to idiopathic hypersomnia without long sleep time. For more details, you can explore ongoing research through ClinicalTrials.gov at https://clinicaltrials.gov/search?cond=idiopathic%20hypersomnia%20without%20long%20sleep%20time.
Actionable guidance for navigating care for idiopathic hypersomnia without long sleep time
To navigate your condition effectively, consider consulting a sleep specialist with expertise in hypersomnia disorders. They can provide tailored management strategies and support. Additionally, engaging with resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and guidance. While there are currently no known patient organizations for this specific condition, participating in clinical trials may also offer access to new treatments and contribute to research efforts.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding idiopathic hypersomnia without long sleep time is largely due to its rarity and the lack of systematic clinical studies. As this condition affects a small population, comprehensive research has been challenging. Additionally, the absence of identified genetic factors and clear clinical features complicates the understanding and characterization of this disorder. However, ongoing research efforts may provide more insights in the future.
To navigate your condition effectively, consider consulting a sleep specialist with expertise in hypersomnia disorders. They can provide tailored management strategies and support. Additionally, engaging with resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and guidance. While there are currently no known patient organizations for this specific condition, participating in clinical trials may also offer access to new treatments and contribute to research efforts.
There are several orphan drugs designated for this condition, including mazindol, pentetrazol, pitolisant, serdexmethylphenidate, and sodium oxybate, although only sodium oxybate has received FDA approval. Currently, there is one active clinical trial related to idiopathic hypersomnia without long sleep time. For more details, you can explore ongoing research through ClinicalTrials.gov at https://clinicaltrials.gov/search?cond=idiopathic%20hypersomnia%20without%20long%20sleep%20time.
Actionable guidance for navigating care for idiopathic hypersomnia without long sleep time
To navigate your condition effectively, consider consulting a sleep specialist with expertise in hypersomnia disorders. They can provide tailored management strategies and support. Additionally, engaging with resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and guidance. While there are currently no known patient organizations for this specific condition, participating in clinical trials may also offer access to new treatments and contribute to research efforts.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding idiopathic hypersomnia without long sleep time is largely due to its rarity and the lack of systematic clinical studies. As this condition affects a small population, comprehensive research has been challenging. Additionally, the absence of identified genetic factors and clear clinical features complicates the understanding and characterization of this disorder. However, ongoing research efforts may provide more insights in the future.
To navigate your condition effectively, consider consulting a sleep specialist with expertise in hypersomnia disorders. They can provide tailored management strategies and support. Additionally, engaging with resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and guidance. While there are currently no known patient organizations for this specific condition, participating in clinical trials may also offer access to new treatments and contribute to research efforts.
There are several orphan drugs designated for this condition, including mazindol, pentetrazol, pitolisant, serdexmethylphenidate, and sodium oxybate, although only sodium oxybate has received FDA approval. Currently, there is one active clinical trial related to idiopathic hypersomnia without long sleep time. For more details, you can explore ongoing research through ClinicalTrials.gov at https://clinicaltrials.gov/search?cond=idiopathic%20hypersomnia%20without%20long%20sleep%20time.
Actionable guidance for navigating care for idiopathic hypersomnia without long sleep time
To navigate your condition effectively, consider consulting a sleep specialist with expertise in hypersomnia disorders. They can provide tailored management strategies and support. Additionally, engaging with resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and guidance. While there are currently no known patient organizations for this specific condition, participating in clinical trials may also offer access to new treatments and contribute to research efforts.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 1 company has orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.